Literature DB >> 21865372

Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).

Hirohito Sone1, Sachiko Tanaka, Shiro Tanaka, Satoshi Iimuro, Koji Oida, Yoshimitsu Yamasaki, Shinichi Oikawa, Shun Ishibashi, Shigehiro Katayama, Yasuo Ohashi, Yasuo Akanuma, Nobuhiro Yamada.   

Abstract

CONTEXT: Risk factors for cardiovascular complications in Japanese patients with diabetes have not been fully elucidated.
OBJECTIVE: Our objective was to determine incidence of and risk factors for coronary heart disease (CHD) and stroke in Japanese diabetic patients. DESIGN AND SETTINGS: We conducted a prospective study at 59 hospitals throughout Japan. PATIENTS: Patients included 940 men and 831 women with type 2 diabetes (mean age, 58.2 yr) without a history of cardiovascular complications who were followed for a median of 7.86 yr. INTERVENTION: This was an observational study. MAIN OUTCOME MEASURES: Incidence of CHD and stroke was evaluated.
RESULTS: Incidences of CHD and stroke per 1000 person-years were 9.59 and 7.45, respectively, whereas those of myocardial and brain infarctions were 3.84 and 6.29, respectively. Multivariate Cox analysis revealed that the serum log-transformed triglyceride level was a potent and independent predictor of CHD [hazard ratio (HR) = 1.54; 95% confidence interval (CI) = 1.22-1.94 per 1 sd increase), comparable to low-density lipoprotein (LDL) cholesterol (HR = 1.49; 95% CI = 1.25-1.78 per 1 sd increase). Triglycerides and LDL cholesterol linearly and continuously increased CHD risk, and subjects in the top third for both had markedly high risks of CHD, and their effects were possibly additive. However, serum triglycerides worked independently of blood pressure levels. Systolic blood pressure was the only significant predictor for stroke except for age (HR = 1.31; 95% CI = 1.04-1.65, per 1 sd increase).
CONCLUSIONS: In Japanese patients with type 2 diabetes, the serum triglyceride level was a leading predictor of CHD, comparable to LDL cholesterol. Because the serum triglyceride level is not a leading predictor of CHD in diabetic subjects in Western countries, ethnic group-specific strategies for prevention of diabetic macroangiopathy may be indicated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865372     DOI: 10.1210/jc.2011-0622

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  66 in total

Review 1.  Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.

Authors:  Yukako Tatsumi; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

Review 2.  Japanese Clinical Practice Guideline for Diabetes 2016.

Authors:  Masakazu Haneda; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Tatsuya Kondo; Eiichi Araki
Journal:  Diabetol Int       Date:  2018-03-27

Review 3.  Blood pressure management in patients with type 2 diabetes mellitus.

Authors:  Hisashi Kai
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

4.  ApoE isoforms, treatment of diabetes and the risk of coronary heart disease.

Authors:  Hideki Ehara; Ritsuko Yamamoto-Honda; Hiroji Kitazato; Yoshihiko Takahashi; Shoji Kawazu; Yasuo Akanuma; Mitsuhiko Noda
Journal:  World J Diabetes       Date:  2012-03-15

Review 5.  Genetic insights into cardiometabolic risk factors.

Authors:  John B Whitfield
Journal:  Clin Biochem Rev       Date:  2014-02

6.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 7.  Japanese Clinical Practice Guideline for Diabetes 2019.

Authors:  Eiichi Araki; Atsushi Goto; Tatsuya Kondo; Mitsuhiko Noda; Hiroshi Noto; Hideki Origasa; Haruhiko Osawa; Akihiko Taguchi; Yukio Tanizawa; Kazuyuki Tobe; Narihito Yoshioka
Journal:  Diabetol Int       Date:  2020-07-24

Review 8.  The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review.

Authors:  Ai-Hua Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

9.  Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS).

Authors:  H Sone; S Tanaka; S Tanaka; S Suzuki; H Seino; O Hanyu; A Sato; T Toyonaga; K Okita; S Ishibashi; S Kodama; Y Akanuma; N Yamada
Journal:  Diabetologia       Date:  2013-02-27       Impact factor: 10.122

10.  Cohort profile: The Japan diabetes complications study: a long-term follow-up of a randomised lifestyle intervention study of type 2 diabetes.

Authors:  Shiro Tanaka; Sachiko Tanaka; Satoshi Iimuro; Hidetoshi Yamashita; Shigehiro Katayama; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada; Hirohito Sone
Journal:  Int J Epidemiol       Date:  2013-05-18       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.